A transfusion risk stratification score to facilitate quality management in cardiopulmonary bypass
- PMID: 37458390
- DOI: 10.1111/trf.17487
A transfusion risk stratification score to facilitate quality management in cardiopulmonary bypass
Abstract
Background: Our previous showed that a blood management program in the cardiopulmonary bypass (CPB) department, reduced red blood cell (RBC) transfusion and complications, but assessing transfusion practice solely based on transfusion rates was insufficient. This study aimed to design a risk stratification score to predict perioperative RBC transfusion to guide targeted measures for on-pump cardiac surgery patients.
Study design and methods: We analyzed data from 42,435 adult cardiac patients. Eight predictors were entered into the final model including age, sex, anemia, New York Heart Association classification, body surface area, cardiac surgery history, emergency surgery, and surgery type. We then simplified the score to an integer-based system. The area under the receiver operating characteristic curve (AUC), Hosmer-Lemeshow goodness-of-fit test, and a calibration curve were used for its performance test. The score was compared to existing scores.
Results: The final score included eight predictors. The AUC for the model was 0.77 (95% CI, 0.76-0.77) and 0.77 (95% CI, 0.76-0.78) in the training and test set, respectively. The calibration curves showed a good fit. The risk score was finally grouped into low-risk (score of 0-13 points), medium-risk (14-19 points), and high-risk (more than 19 points). The score had better predictive power compared to the other two existing risk scores.
Discussion: We developed an effective risk stratification score with eight variables to predict perioperative RBC transfusion for on-pump cardiac surgery. It assists perfusionists in proactively preparing blood conservation measures for high-risk patients before surgery.
Keywords: blood management; cardiac surgery; cardiopulmonary bypass; risk prediction score; transfusion.
© 2023 AABB.
Comment in
-
In response: Caution in prediction: Evaluating Zhang et al.'s approach to red blood cell transfusion risk.Transfusion. 2024 Mar;64(3):560-561. doi: 10.1111/trf.17731. Transfusion. 2024. PMID: 38488273 No abstract available.
References
REFERENCES
-
- Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C, Dunbar NM, et al. Transfusion reactions: prevention, diagnosis, and treatment. Lancet. 2016;388:2825-2836.
-
- Carson JL, Triulzi DJ, Ness PM. Indications for and adverse effects of red-cell transfusion. N Engl J Med. 2017;377:1261-1272.
-
- Murphy GJ, Reeves BC, Rogers CA, Rizvi SIA, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544-2552.
-
- Paone G, Likosky DS, Brewer R, Theurer PF, Bell GF, Cogan CM, et al. Transfusion of 1 and 2 units of red blood cells is associated with increased morbidity and mortality. Ann Thorac Surg. 2014;97:87-93.
-
- Shander AS, Goodnough LT. Blood transfusion as a quality indicator in cardiac surgery. JAMA. 2010;304:1610-1611.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
